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Effect of a Pediatric Early Warning System on All-Cause
Mortality in Hospitalized Pediatric Patients
The EPOCH Randomized Clinical Trial
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Editorial page 981
IMPORTANCE There is limited evidence that the use of severity of illness scores

in pediatric patients can facilitate timely admission to the intensive care unit or improve
patient outcomes.
OBJECTIVE To determine the effect of the Bedside Paediatric Early Warning System
(BedsidePEWS) on all-cause hospital mortality and late admission to the intensive care unit
(ICU), cardiac arrest, and ICU resource use.
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DESIGN, SETTING, AND PARTICIPANTS A multicenter cluster randomized trial of 21 hospitals
located in 7 countries (Belgium, Canada, England, Ireland, Italy, New Zealand, and the
Netherlands) that provided inpatient pediatric care for infants (gestational age ⱖ37 weeks) to
teenagers (aged ⱕ18 years). Participating hospitals had continuous physician staffing and
subspecialized pediatric services. Patient enrollment began on February 28, 2011, and ended
on June 21, 2015. Follow-up ended on July 19, 2015.
INTERVENTIONS The BedsidePEWS intervention (10 hospitals) was compared with usual care

(no severity of illness score; 11 hospitals).
MAIN OUTCOMES AND MEASURES The primary outcome was all-cause hospital mortality.
The secondary outcome was a significant clinical deterioration event, which was defined
as a composite outcome reflecting late ICU admission. Regression analyses accounted
for hospital-level clustering and baseline rates.
RESULTS Among 144 539 patient discharges at 21 randomized hospitals, there were 559 443
patient-days and 144 539 patients (100%) completed the trial. All-cause hospital mortality
was 1.93 per 1000 patient discharges at hospitals with BedsidePEWS and 1.56 per 1000
patient discharges at hospitals with usual care (adjusted between-group rate difference, 0.01
[95% CI, −0.80 to 0.81 per 1000 patient discharges]; adjusted odds ratio, 1.01 [95% CI, 0.61
to 1.69]; P = .96). Significant clinical deterioration events occurred during 0.50 per 1000
patient-days at hospitals with BedsidePEWS vs 0.84 per 1000 patient-days at hospitals with
usual care (adjusted between-group rate difference, −0.34 [95% CI, −0.73 to 0.05 per 1000
patient-days]; adjusted rate ratio, 0.77 [95% CI, 0.61 to 0.97]; P = .03).
CONCLUSIONS AND RELEVANCE Implementation of the Bedside Paediatric Early Warning

System compared with usual care did not significantly decrease all-cause mortality among
hospitalized pediatric patients. These findings do not support the use of this system to
reduce mortality.
TRIAL REGISTRATION clinicaltrials.gov Identifier: NCT01260831
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T

he prevention of near and actual cardiopulmonary arrest is a fundamental element of patient safety. Prevention is contingent on the timely identification, referral, and treatment of hospitalized children who are clinically
deteriorating. Implementation of severity of illness scores or
criteria with or without a rapid response team may facilitate
timely admission to the intensive care unit (ICU) and the delivery of critical care to improve patient outcomes.1 To date,
interventional studies in children have used before and after
designs that may be confounded by temporal trends and limited by a predominance of single-center evaluations.2-6
The Bedside Paediatric Early Warning System (BedsidePEWS)
is a documentation-based system of care composed of a validated severity of illness score, an interprofessionally designed
documentation record, and multidomain recommendations for
care escalation and de-escalation among hospitalized patients
from term to 18 years of age.7-10
A cluster randomized clinical trial was designed and
conducted to test the hypothesis that implementation of
BedsidePEWS would reduce rates of all-cause hospital mortality and significant clinical deterioration among hospitalized children compared with usual care at hospitals without
an early warning score.

Methods
Study Design
A detailed description of the study rationale, design, interventions, and outcomes was described previously11 and appears in Supplement 1 and Supplement 2. Research ethics board
approval was obtained at each participating hospital. The need
for written informed consent for patient or clinician participation was waived in all jurisdictions. This 21-center cluster
randomized clinical trial was coordinated by the Center for
Safety Research at the Hospital for Sick Children, in Toronto,
Ontario, Canada, and was overseen by the study executive
steering committee and the Canadian Critical Care Trials Group.
Eligibility criteria were based on hospital, inpatient unit,
and patient criteria. Hospitals were included if they had a pediatric ICU and if their hospital leadership agreed to randomization. Hospitals with rapid response teams were eligible to
participate. Eligible inpatient units were defined as areas in
which care was provided to pediatric inpatients, including
emergency departments that used inpatient documentation
records to care for admitted patients.
Hospitals were ineligible if they were already using a severity of illness score on inpatient units, or were planning to
introduce or discontinue a rapid response team. Ineligible inpatient units were ICUs, areas designated for anesthesiologistsupervised procedures, and high-dependency units in which
critical care physicians supervised care.
Infant (gestational age ≥37 weeks) to adolescent (aged ≤18
years) patients were included if they had received care in 1 or
more eligible inpatient units. Participating hospitals were randomized in a 1:1 ratio to either the BedsidePEWS intervention
or usual care using a computer-generated random sequence.
Randomization was within 2 strata of hospital size (<200 and
jama.com
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Key Points
Question Does the implementation of the Bedside Paediatric
Early Warning System (BedsidePEWS) reduce hospital mortality
compared with no severity of illness score?
Findings In this cluster randomized trial that included 21 hospitals,
144 539 patient discharges, and 559 443 patient-days,
implementation of the BedsidePEWS compared with usual care
did not significantly decrease all-cause mortality among
hospitalized pediatric patients (1.93 per 1000 discharges vs 1.56
per 1000 discharges, respectively).
Meaning This study does not support the use of the
BedsidePEWS to reduce hospital mortality.

≥200 eligible inpatient ward beds). A block size of 4 was used
for both strata, and was only known by the study statistician.
Randomization and disclosure of the resulting site allocation
occurred during the second week of data collection at each site.
During the first 26 weeks, an interprofessional team at the
Center for Safety Research supported implementation teams
at hospitals randomized to the intervention as they led local
preparations. The implementation of the intervention involved several steps. First, the inpatient unit–based vital sign
documentation was changed to the paper-based BedsidePEWS
documentation record. The chart designed by health care professionals enabled documentation and graphical presentation of individual vital signs, and manual calculation of the
BedsidePEWS score. The BedsidePEWS score ranges from 0 to
26, with higher scores indicating greater severity of illness. Five
age-specific paper documentation records for each of the age
groups of the BedsidePEWS score were introduced at each hospital. Second, the language of the BedsidePEWS recommendations for care escalation and de-escalation were revised to
match the local vernacular. These recommendations encompassed multiple domains including documentation frequency, physician review, and ICU consultation and were
printed on each documentation record. Third, locally relevant education programs were developed and delivered 1 to
2 months prior to clinical implementation, which began during week 26 as the study run-in phase.11
ImplementationinvolvedtheroutineuseoftheBedsidePEWS
documentation record and the score-matched care recommendations for all patients admitted to eligible inpatient unit
beds. The BedsidePEWS intervention was continued throughout the 52-week intervention period (Figure 1).
Hospitals with usual care (control) did not receive a new
prospective severity score to help identify children at risk of
significant clinical deterioration during the study, but continued to use preexisting rapid response teams, ICU consultation mechanisms, and resuscitation teams.
During the run-in phase, adherence to the BedsidePEWS
documentation recommendations was assessed by review of
documentation frequency and scoring accuracy. The study executive steering committee reviewed weekly adherence data
leading to either extension of the 5-week run-in phase or transition to active data collection during the intervention period. Ongoing review of adherence included practice audits
with local reporting at implementation hospitals.
(Reprinted) JAMA March 13, 2018 Volume 319, Number 10
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Figure 1. Hospital Site and Patient Flow Through Study
34 Hospitals assessed for eligibility
11 Hospitals excluded
1 Did not meet inclusion criteria
10 Refused to participate

23 Hospitals randomizeda

12 Hospitals randomized to Bedside
Paediatric Early Warning Systemb

11 Hospitals randomized to usual carec

Baseline period
10 Hospitals received intervention as
randomized (mean No. of pediatric
beds, 94; range, 11-222)d
129 700 Patient-days (mean, 12 970;
range, 1133-30 571)
26 664 Discharges (mean, 2666;
range, 467-6698)e
2 Hospitals did not receive intervention
as randomized (mean No. of pediatric
beds, 81; range, 65-97)d,f
13 769 Patient-days (mean, 6885;
range, 164-13 605)
3134 Discharges (mean, 1567;
range, 32-3102)e

Baseline period
11 Hospitals received intervention as
randomized (mean No. of pediatric
beds, 104; range, 51-203)d
162 497 Patient-days (mean, 14 772;
range, 6665-31 575)
46 718 Discharges (mean, 4247;
range, 1762-13 308)e

3 Hospitals had run-in extension for
an additional 1, 5, and 6 wkg
Intervention period
10 Hospitals received intervention
251 859 Patient-days (mean, 25 186;
range, 2270-56 231)
50 173 Discharges (mean, 5017;
range, 837-11 370)

Intervention period
11 Hospitals received intervention
307 584 Patient-days (mean, 27 962;
range, 13 034-61 270)
94 366 Discharges (mean, 8579;
range, 3672-29 956)

0 Discharges lost to follow-up
0 Hospitals discontinued intervention

0 Discharges lost to follow-up
0 Hospitals discontinued intervention

10 Hospitals included in primary analysis
251 859 Patient-days (mean, 25 186;
range, 2270-56 231)
50 173 Discharges (mean, 5017;
range, 837-11 370)

11 Hospitals included in primary analysis
307 584 Patient-days (mean, 27 962;
range, 13 034-61 270)
94 366 Discharges (mean, 8579;
range, 3672-29 956)

a

Enrollment began in 2011 for 8 hospitals, in 2012 for 10 hospitals, and in 2013
for 5 hospitals. Disclosure of randomization to the hospital occurred during the
second week of the 26-week baseline period.

e

Discharges were all eligible patients discharged from the hospital and included
the patients who died. Patients who were in the hospital at the end of the
study period were regarded as discharged.

b

Hospitals randomized to the BedsidePEWS intervention collected data during
the 26-week baseline period as they prepared for implementation of the
intervention. During the 5-week run-in phase, adherence to vital sign
documentation was assessed and reported to the study executive steering
committee. Implementing hospitals required a minimum of 80% adherence to
documentation standards and the majority vote of the executive steering
committee to move into the intervention period.

f

Unable to adhere to implementation timelines specified by the study and were
excluded before implementation. These hospitals were regional pediatric
centers. One hospital had a rapid response team and no extracorporeal
membrane oxygenation and the other did not have a rapid response team but
had extracorporeal membrane oxygenation. The numbers of patient-days and
patient discharges reported reflect the amount of data received from each
hospital before they withdrew from the study.

c

Hospitals randomized to usual care collected data during the 26-week baseline
period, did not collect data during the 5-week run-in phase, and then resumed
data collection for the 52-week intervention period.

g

The 5-week run-in phase included weekly assessment beginning during the
second week of implementation.

d

Did not include beds in the intensive care unit.

Hospitals randomized to usual care resumed data collection after a 5-week hiatus. Documentation practices were reviewed to reflect implementation fidelity at BedsidePEWS hospitals and documentation practice at control hospitals. Five
patients who had been on an eligible inpatient ward for more
than 24 hours were randomly selected from each hospital dur1004

ing each study week. The number of documented assessments were abstracted for each of 7 clinical observation types,
and the number of clinical observation types in the most recent set of clinical observations was counted.
The analysis of clinical documentation completeness was revised from the protocol-specified method before the analyses

JAMA March 13, 2018 Volume 319, Number 10 (Reprinted)
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were conducted. Instead of evaluating all sets of documented clinical observations, the last 1 was selected. The
threshold number of observations within that set of observations was reduced from 7 to 5 to be consistent with the minimum number of observations recommended to calculate
a BedsidePEWS score.

Study Outcomes
The primary outcome was all-cause hospital mortality. This included deaths among children with do-not-resuscitate (DNR)
orders because the DNR order reflects current expectations of
outcome rather than the preventability of the clinical events
that preceded the DNR order. Among hospitalized pediatric patients, the majority of deaths occur remote from the clinical
deterioration event (within days),12-15 and there is a relatively
short period (within hours) between following the DNR order
and death.16-18 Thus, the placement of a DNR order may not
provide a good separation between potentially preventable and
unpreventable death.
The main secondary outcome was the significant clinical
deterioration event. This measure of late ICU admission was
a composite outcome that occurred among patients without
DNR orders and was composed of 1 or more of the following:
death before ICU admission; provision of cardiopulmonary resuscitation, tracheal intubation, administration of vasoactive medication, or provision of fluid boluses of 60 mL/kg or
greater within the 12 hours before ICU admission; tracheal intubation, cardiopulmonary resuscitation, initiation of extracorporeal membrane oxygenation, or death within the first
hour of ICU admission.
The study protocol included 21 other prespecified
outcomes.11 The outcomes included mortality without a DNR,
ICU mortality (overall and after urgent ICU admission), potentially preventable cardiac arrest, unplanned ICU readmission
and hospital readmission within 48 hours, predicted mortality using severity of illness at ICU admission, organ dysfunction in the ICU, and ventilator-free days in the ICU among patients urgently admitted to ICU.
Urgent ICU admission was defined as (1) transfer to the ICU
within 6 hours of the transfer decision from an eligible inpatient unit and (2) transfer initiated while an eligible patient was
in the operating room. This definition intentionally incorporated patients in which preoperative review may have identified candidates for elective postoperative ICU admission,
and recognizing that unexpected intraoperative complications (in previously well patients) that lead to ICU admission
are uncommon.11
The potential preventability of cardiac arrest was defined
as the degree to which events may have been avoided given
the application of reasonable current standards of practice
by an average practitioner and system anticipated to manage
the condition in question. The assessment method was based
on a validated approach used to evaluate clinical data describing cardiac arrest and other adverse events.19-21 Blinded review by 2 independent experts resulted in either initial agreement or discussion leading to a consensus rating. Assessment
ratings of preventable by greater than 50% were deemed potentially preventable.11
jama.com
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For each urgent ICU admission, the revised Paediatric
Index of Mortality (PIM2) score,22,23 organ dysfunction using
the Paediatric Logistic Organ Dysfunction score,24 and ICU mortality were determined. If a patient had more than 1 admission, the mean was used. Ventilator-free days were determined for the 28 days after the first ICU admission during each
study period. Complementing the above prespecified outcomes, we report rates of ward-based cardiac arrest and urgent ICU admission, and the PIM2 score at ICU admission.
These outcomes were not prespecified.
The process of care outcomes were immediate calls for
a physician, immediate calls for the resuscitation team,
consultations to the ICU or rapid response team (response
within 15 minutes), and documentation of clinical observations. Resource use among patients after urgent ICU admission was assessed by the ICU length of stay and the days in
which mechanical ventilation, high-frequency oscillatory ventilation, hemodialysis, extracorporeal membrane oxygenation, and nitric oxide were used. Definitions of these outcomes appear in eTable 1 in Supplement 3. The perceptions of
frontline staff and administrators were sought using surveys
and are not reported herein. Data were collected by trained research coordinators.

Sample Size and Assumptions
Power calculations were based on data from 2007 to 2009
using an established method for cluster randomized trials.25
We assumed a baseline all-cause hospital mortality of 5.1
deaths per 1000 hospital discharges and estimated a mortality reduction of 1 per 1000 hospital discharges (from 5.1 to 4.1)
to be sufficient to change practice. Given a κ of 0.15 (intercluster coefficient of variation), inclusion of 20 hospitals randomized in a 1:1 ratio with an average of 119 beds, occupancy of
0.90, and average hospital stay of 4 days could show an absolute risk reduction of 0.9 per 1000 hospital discharges for mortality with 2-sided type I error probability of .05 and 80%
power. Assuming attrition of 1 to 2 hospitals, we planned to
enroll 22 hospitals.11

Data Analyses
Demographic and unadjusted outcomes data are reported using
descriptive statistics, medians with interquartile ranges, means
and SDs, as proportions with 95% CIs, and as rate differences
with 95% CIs. Patient outcomes are expressed as rates per
1000 eligible patients discharged from the hospital (all-cause
mortality, hospital readmission), per 1000 ICU discharges (ICU
mortality), per 1000 patient-days in the ICU (ICU outcomes),
and per 1000 patient-days on eligible inpatient units (other outcomes). Outcomes are reported for the baseline and intervention periods for each hospital as recommended for cluster randomized trials26 using odds ratios (ORs) or rate ratios and
between-group rate differences with 95% CIs.
Generalized estimating equation models with an exchangeable correlation structure and grouping by center were used
to compare outcomes between centers assigned to BedsidePEWS and usual care. Binary outcomes used a logistic model,
count outcomes used a Poisson model with patient-days as
an offset, and continuous outcomes used a Gaussian model.
(Reprinted) JAMA March 13, 2018 Volume 319, Number 10
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Table 1. Baseline Characteristics of Intervention and Control Hospitals (N = 21)
Characteristic

BedsidePEWS

Usual Care

No. of hospitalsa

10

11

No. of total beds

5172

3169

937

1148

No. of pediatric bedsb
<200, No. (%)

8 (80)

10 (91)

≥200, No. (%)

2 (20)

1 (9)

Hospital Services, No. (%)
Rapid response team

5 (50)

4 (36)

Affiliated with university

8 (80)

11 (100)

Emergency department

9 (90)c

11 (100)

Cardiopulmonary bypass

5 (50)

7 (64)

Extracorporeal membrane oxygenation

5 (50)

8 (73)

Solid organ transplant

5 (50)

7 (64)

Bone marrow transplant

4 (40)

6 (55)

Pediatric-trained staff physician

4 (40)

3 (27)

Fellow

1 (10)

3 (27)

Resident

5 (50)

5 (45)

ICU staff physician

2 (20)

ICU fellow
Resident

Hospital Staffing
Most senior ward physician in-house overnight, No. (%)d

Abbreviations: BedsidePEWS,
Bedside Paediatric Early Warning
System; ICU, intensive care unit.
a

Had a pediatric ICU, pediatric
trainees, staff physicians for the
pediatric ICU, and pediatric
surgeons. All hospitals remained
eligible throughout the course of
the study.

1 (9)

b

Excluded ICU beds.

5 (50)

3 (27)

c

1 (10)

7 (64)

8 (80)

8 (73)

One hospital without an emergency
department provided care to
specialized patient populations and
accepted patients from other
facilities.

d

All had 1 or more physicians
in-house continuously.

e

Included pediatric emergency
physicians or other pediatric
trainees.

f

Patients who were inpatients at the
end of the baseline or intervention
periods were regarded as
discharged from the hospital.

Most senior ICU physician in-house overnight, No. (%)

Emergency physicians available overnight, No. (%)e
No. of full-time equivalent nurses
<0.5

169

117

0.5-0.9

467

962

>0.9

749

1070

Hospital Volume, No.
Patient dischargesf
Patient-days
ICU patient dischargesf

26 664

46 718

129 700

162 497

1859

2599

To estimate absolute differences in rates and proportions, the
logistic and Poisson models were fitted using an identity link
function. If the generalized estimating equation model with
the identity link did not converge, the differences and their 95%
CIs were calculated using the corresponding model without
adjusting for baseline.
Hospital-level data were used for mortality, readmission
and resuscitation team calls, stat calls, and ICU consultation.
In each analysis, the 2 predictors were a binary variable for
intervention and the center’s baseline summary value of the
corresponding outcome. Individual-level data were used for
analyses of urgent ICU admission outcomes and accounted for
clustering within center. An interim analysis was neither
planned nor performed.
A 2-sided P value of .05 was regarded as significant. Post
hoc adjustment for multiple comparisons of the 21 prespecified outcomes used the method of Holm. The assumptions supporting the trial sample size calculation and those found after its conduct were tabulated to enable post hoc comparison.
The analytic team were not blinded to the treatment allocation. Four planned subgroup analyses including hospitals with
1006

and without rapid response teams were described in the protocol, but are not reported herein.

Results
Thirty-four hospitals were screened for enrollment in this
study. Twenty-three hospitals met the eligibility criteria. The
21 hospitals that completed the study were located in Belgium,
Canada, England, Ireland, Italy, New Zealand, and the Netherlands and had a total of 2085 eligible inpatient unit beds
(Figure 1). Hospitals had a range of pediatric services including cardiopulmonary bypass, solid organ transplantation, and
bone marrow transplantation, and all had pediatric trainee physicians and continuous in-house physician staffing (Table 1).
Because only 3 hospitals had more than 200 eligible inpatient beds, the planned stratification was removed from the
statistical analysis.
Enrollment was initiated on February 28, 2011, and ended
on June 21, 2015. Follow-up was completed on July 19, 2015.
There were 73 382 hospital discharges and 292 197 patient-days
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Table 2. Measurements to Assess the Completeness of the Documented Clinical Observations Among Randomly Selected Patientsa
Mean No. of Measurements (SD)b
BedsidePEWS

Total No. of patient assessments

Usual Care

Baseline
Period

Intervention
Period

Baseline
Period

Intervention
Period

1270

2588

1419

2832

P Value

Adjusted
P Valued

Heart rate

6.97 (5.1)

7.40 (4.8)

6.48 (4.9)

6.45 (4.7)

0.58 (−0.11 to 1.26)

.10

Respiratory rate

6.99 (5.5)

7.38 (4.9)

5.59 (4.2)

5.53 (4.0)

0.85 (0.02 to 1.68)

.05

.18

Systolic blood pressure

4.09 (4.2)

5.05 (3.5)

3.58 (4.5)

3.59 (3.6)

1.12 (0.59 to 1.65)

<.001

<.001

Transcutaneous oxygen saturation

6.64 (5.3)

7.30 (5.0)

5.29 (5.4)

5.21 (5.3)

1.06 (0.27 to 1.85)

.009

.04

Respiratory effort

1.99 (3.6)

7.16 (4.7)

2.80 (3.3)

3.00 (3.6)

4.67 (3.23 to 6.12)

<.001

<.001

Capillary refill

1.96 (3.5)

6.66 (4.4)

1.48 (3.0)

1.66 (3.1)

4.65 (3.49 to 5.80)

<.001

<.001

Oxygen therapy

6.80 (5.2)

7.30 (4.8)

5.83 (5.6)

6.09 (5.7)

0.37 (−0.71 to 1.46)

.50

>.99

<.001

<.001

Observation sets with ≥5 vital signs,
No. (%)

960 (75.6) 2563 (99.0)

883 (62.2)

At each hospital during each study week, 5 patients admitted to a ward for at
least 24 hours were randomly selected for documentation review. Study
coordinators abstracted the number of documented measurements during
the 24 hours before assessment for each of the 7 clinical observations in this
Table and abstracted the number of clinical observation types included in the
last set of clinical observations. A set of clinical observations was regarded as
those that were documented as being from the same time. There were 8190
(21 sites × 5 patients per week × [26 + 52] weeks) case report forms
anticipated and 8109 (99%) were obtained. The missing data may reflect the
challenges of finding 5 randomly selected patients admitted for more than

during the baseline period and 144 539 hospital discharges and
559 443 patient-days during the intervention period. There was
no loss to follow-up for study events.
The frequency of documentation increased at the
BedsidePEWS hospitals for 5 of the 7 clinical observation types
reviewed (Table 2). At the BedsidePEWS hospitals compared
with the usual care hospitals, the difference in the number of
documented observations within 24 hours increased for respiratory rate by a mean of 0.85 (95% CI, 0.02-1.68; P = .05); systolic blood pressure, 1.12 (95% CI, 0.59-1.65; P < .001); transcutaneous oxygen saturation, 1.06 (95% CI, 0.27-1.85; P = .009);
respiratory effort, 4.67 (95% CI, 3.23-6.12; P < .001); and capillary refill, 4.65 (95% CI, 3.49-5.80; P < .001). The overall proportion of sets of clinical observations with 5 or more of the 7
clinical observation types reviewed increased by 38.1% (95% CI,
20.8%-55.4%) at BedsidePEWS hospitals compared with usual
care hospitals (P < .001) (eFigure 2 in Supplement 3).

Primary Outcome
For the primary outcome of all-cause mortality, there were 244
deaths that occurred at the hospital, corresponding to 1.69 per
1000 patient discharges and including 155 deaths (63.5%) after
DNR orders (Table 3). During the baseline period, there were no
deaths at 4 hospitals. During the 52-week intervention period,
there were fewer than 10 deaths at 13 hospitals (Figure 2 and
eTable 2 in Supplement 3). Hospital mortality was 1.93 per 1000
patient discharges at the BedsidePEWS hospitals compared with
1.56 per 1000 patient discharges at usual care hospitals.
The primary analysis found no significant differences between the BedsidePEWS and usual care hospitals (adjusted
between-group rate difference, 0.01 [95% CI, −0.80 to 0.81 per
jama.com

1725 (60.9)

38.1 (20.8 to 55.4)e

.30

24 hours at a smaller hospital, and in some cases, the fifth patient may have
been unintentionally missed.

Abbreviation: BedsidePEWS, Bedside Paediatric Early Warning System.
a

Between-Group Mean
Difference (95% CI)c

b

Unless otherwise indicated.

c

Calculated from a generalized estimating equation linear regression model
that adjusted for clustering by hospital using an exchangeable correlation
structure. The BedsidePEWS group and the hospital baseline mean value were
used as predictors.

d

Adjustment for multiple comparisons was performed using the method of Holm.

e

Calculated using a generalized estimating equation regression model with a
binomial variance and a linear link function. The BedsidePEWS group and the
hospital baseline proportion were the only covariates.

1000 patient discharges]; adjusted OR, 1.01 [95% CI, 0.61 to
1.69]; P = .96). Hospital mortality among patients without a
DNR was 0.84 per 1000 discharges at the BedsidePEWS hospitals compared with 0.50 per 1000 discharges at the usual care
hospitals (adjusted between-group rate difference, 0.36 [95%
CI, −0.53 to 1.25 per 1000 patient discharges]; adjusted OR, 2.05
[95% CI, 0.64 to 6.61]; P = .23).

Secondary Outcome
There were 386 (127 at BedsidePEWS hospitals vs 259 at usual
care hospitals) significant clinical deterioration events (Table 3).
This corresponded to rates of 0.50 per 1000 patient-days at
BedsidePEWS hospitals compared with 0.84 per 1000 patient days at usual care hospitals (P = .03). The baselineadjusted rate ratio was 0.77 (95% CI, 0.61 to 0.97) and the adjusted between-group rate difference was −0.34 (95% CI, −0.73
to 0.05) events per 1000 patient-days. Significant clinical deterioration events comprised 15.3% of urgent ICU admissions
of eligible patients at BedsidePEWS hospitals and 22.0% at
usual care hospitals and included 59 cardiac arrest events and
8 deaths before transfer to the ICU.

Other Outcomes
There were no significant differences in the rates of cardiac arrest, potentially preventable cardiac arrest, unplanned ICU readmission, or hospital readmission (Table 3); however, individual hospital rates were low (eTable 3 in Supplement 3).
The 1653 patients with urgent ICU admission in the perpatient analysis remained in ICU for 15 212 days and received
mechanical ventilation for 6400 days. There were no significant between-group differences for the severity of illness at
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64

Cardiac arreste

Potentially preventable cardiac arreste,i

Immediate call for resuscitation teame

64

ICU readmission <48 hh
3.79

34.43

3.62

3.69

7.76

0.49

0.08

0.12

1.24

17.75

0.62

170

94

828

1015

1727

126

21

27

56

56

127

42

97

251 859

50 173

3.39

28.40

3.29

4.03

6.86

0.50

0.08

0.11

1.12

16.92

0.50

0.84

1.93

Rate

Rates expressed per 1000 patient discharges from the hospital.

Logistic regression was used. Analyses included adjustment for baseline event rates and used the generalized
estimating equation approach to group data by center to account for clustering.

Rates expressed per 1000 patient-days.

Poisson regression was used. Analyses included adjustment for baseline event rates and used the generalized
estimating equation approach to group data by center to account for clustering.

d

e

f

Data were used for the rate calculations.

b

c

Calculated using binomial and Poisson generalized estimating equation models with an identity link function and
adjustment for baseline values. For significant clinical deterioration, cardiac arrest, immediate call for physician,
and hospital readmission, the model was not adjusted for baseline values.

201

73

652

928

844

97

12

18

34

34

144

16

61

162 497

46 718

a

Abbreviations: DNR, do-not-resuscitate; ICU, intensive care unit; OR, odds ratio; RR, rate ratio.

101

469

Urgent ICU admissione

Hospital readmission <48 hc

478

Urgent (<15 min) ICU consultatione

Immediate call for physiciane,j
1007

33

c

ICU mortality

33

ICU mortalityh

Post hoc Outcomes

g

Significant clinical deterioration evente
80

0.98

26

All-cause hospital mortality
without a DNR orderc

Secondary Outcome

1.95

52

129 700

26 664

Rate

All-cause hospital mortalityc

Primary Outcome

Patient-daysb

Patient discharges

b

Assessed by 2 blinded expert reviewers using a 6-point scale. A rating of 4 indicates more than likely
preventable. Weighted κ, 0.35 (95% CI, 0.15-0.51) for agreement of initial reviewer ratings. Discussion between
the 2 reviewers increased agreement such that arbitration by the third reviewer was used for only 5 events.
There were 21 (77.8%) cardiac arrest events rated as potentially preventable at the BedsidePEWS hospitals vs 29
(90.6%) events at the control hospitals.
Determined from multiple potentially overlapping sources (eg, switchboard paging logs, ward clerk
documentation, review of patients with events, and other hospital reports). The customized approach taken at
each hospital was developed as part of site coordinator training provided by the coordinating center and was
applied consistently throughout the study at each site.

j

.74

.58

.45

.64

.52

.83

.62

.92

.88

.69

Rates expressed per 1000 discharges from the ICU.

OR, 0.93 (0.61 to 1.41)d

OR, 1.11 (0.77 to 1.61)d

RR, 0.95 (0.82 to 1.09)f

RR, 1.05 (0.85 to 1.30)f

RR, 1.17 (0.73 to 1.88)f

RR, 0.98 (0.82 to 1.17)f

RR, 0.87 (0.49 to 1.54)f

RR, 1.02 (0.65 to 1.62)f

OR, 0.95 (0.48 to 1.86)d

OR, 0.89 (0.51 to 1.57)d

.03

.23

OR, 2.05 (0.64 to 6.61)d

RR, 0.77 (0.61 to 0.97)f

.96

OR, 1.01 (0.61 to 1.69)d

P Value

i

−0.71 (−4.92 to 3.49)

4.95 (−1.62 to 11.52)

−0.18 (−0.67 to 0.30)

0.16 (−0.57 to 0.89)

3.10 (−1.92 to 8.11)

0.02 (−0.07 to 0.10)

−0.02 (−0.07 to 0.02)

0 (−0.06 to 0.07)

−0.11 (−0.73 to 0.51)

−3.01 (−12.26 to 6.25)

−0.34 (−0.73 to 0.05)

0.36 (−0.53 to 1.25)

0.01 (−0.80 to 0.81)

Adjusted Ratio (95% CI)

h

4.10

21.25

3.83

5.51

3.76

0.58

0.09

0.10

0.96

17.90

0.84

0.50

1.56

Adjusted Between-Group
Rate Difference (95% CI)a

The analyses of these outcomes should be regarded as exploratory. There was adjustment for multiple
comparisons using the Holm method and yielded P values of >.99 for these 10 outcomes.

387

108

1178

1694

1157

179

29

32

91

91

259

47

147

307 584

94 366

Rate

Intervention Period
No. of
Events

g

4.30

28.09

4.01

5.71

5.19

0.60

0.07

0.11

0.73

13.08

0.89

0.34

1.31

Rate

No. of
Events

No. of
Events

No. of
Events

Usual Care
Baseline Period

Intervention Period

BedsidePEWS
Baseline Period

Table 3. Study Outcomes for Bedside Paediatric Early Warning System (BedsidePEWS) vs Usual Care
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Figure 2. Mortality by Hospital
BedsidePEWS (10 hospitals)
Usual care (11 hospitals)
7
Hospital dischargesa

Deaths per 1000 Discharges During Intervention Period
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6

7

Deaths per 1000 Discharges During Baseline and Intervention Periods

All-cause hospital mortality rates during the baseline and intervention periods
are presented by hospital. Each circle represents a hospital. The circle center
reflects the coordinates of the baseline and intervention mortality rates.
The colored lines represent the linearized fitted relationships between
mortality during the baseline and intervention periods for the BedsidePEWS
intervention hospitals (dashed orange line) and usual care hospitals
(solid blue line). The estimated difference in the slopes between the
BedsidePEWS (slope = 0.57) and the usual care group (slope = 0.53) was
not statistically significantly different from 0 (P = .94). In the analysis,

ICU admission, organ dysfunction, ventilator-free days, and
resource use (eTable 4 in Supplement 3).
There were 109 deaths during the course of urgent ICU admission (42 [6.1%] in BedsidePEWS hospitals vs 67 [6.9%] in
usual care hospitals; adjusted between-group difference,
−1.55% [95% CI, −4.90% to 1.80%], P = .36). The mortality rate
predicted by the PIM2 score was 5.5% at the BedsidePEWS hospitals vs 4.6% at usual care hospitals (adjusted betweengroup difference, 0.69% [95% CI, −0.54% to 1.92%], P = .27).
There were 2884 calls for immediate physician review,
2709 urgent (<15 minutes) ICU consultations, and 305 immediate calls for resuscitation teams (Table 3). There were no
significant differences in calls for immediate physician
review (adjusted between-group rate difference, 3.10 [95%
CI, −1.92 to 8.11 per 1000 patient-days]; adjusted rate ratio,
1.17 [95% CI, 0.73 to 1.88]; P = .52), in immediate calls for the
resuscitation team (adjusted between-group rate difference,
0.02 [95% CI, −0.07 to 0.10 per 1000 patient-days]; adjusted
rate ratio, 0.98 [95% CI, 0.82 to 1.17]; P = .83), or for urgent
ICU consultation (adjusted rate ratio, 1.05 [95% CI, 0.85 to
1.30]; adjusted between-group rate difference, 0.16 [95% CI,
−0.57 to 0.89], P = .64).
jama.com

the slopes were assumed to be equal. In Supplement 3, eFigure 1 provides
linkage of these hospital-level mortality data to additional information about
the individual hospitals contained in eTables 2 and 3.
a

The circle size is proportional to the number of discharges during the
intervention period of that hospital. Thus hospitals with larger circles are
contributing more data and will have narrower 95% CIs for the true values
of their mortality rates.

Discussion
In this international cluster randomized trial comparing implementation of the BedsidePEWS intervention vs usual care, the
BedsidePEWS intervention did not significantly decrease allcause mortality among hospitalized pediatric patients. The 95%
CI for the between-group difference excludes a difference of
greater than 0.8 deaths per 1000 hospital discharges in either
direction (47% relative change). Exploratory analyses did not
find significant reductions in mortality without DNR orders or
ICU mortality. Together these findings do not support the use
of the BedsidePEWS intervention to reduce mortality.
Despite the observed rate of all-cause hospital mortality
being lower than anticipated (1.69 vs 5.10 per 1000 patient discharges), the observed variability between hospitals (0-5.21 per
1000 discharges) was similar to that anticipated before the trial
(eTable 5 in Supplement 3). This may reflect a floor effect of 0
mortality that reduced between-hospital variability. There were
4 hospitals that had no deaths during the baseline period, and
1 had no deaths during the intervention period. If hospitals with
higher expected mortality had been enrolled, variability may
(Reprinted) JAMA March 13, 2018 Volume 319, Number 10
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have been reduced; however, exclusion of smaller regional pediatric centers would have reduced the generalizability of the
trial results.
The composite outcome used to measure late ICU admission (significant clinical deterioration events) was significantly reduced in hospitals implementing the BedsidePEWS
intervention. This isolated positive finding was not accompanied by significant effects on cardiac arrest, urgent ICU admission, mortality after urgent ICU admission, risk-adjusted ICU
mortality, or ICU resource use. These latter findings contrast
with the data underpinning the Society of Critical Care Medicine 2016 guidelines for adult ICU admission27 and suggestions that other measures of timeliness of ICU admission among
pediatric patients are associated with ICU outcomes.28,29 It is
possible that among urgent pediatric ICU admissions, late ICU
admissions may constitute too small a proportion to modify
overall mortality or ICU resource use, or that the indication for
cardiorespiratory intervention was a greater determinant of patient outcome than the time that the intervention was initiated relative to ICU admission.
Exploratory analyses found no significant betweengroup difference in cardiac arrest among patients without
a DNR order. Rates were similar to previous single-center
reports.30,31 Eight cardiac arrests (14%) resulted in death before ICU admission, and most were judged to be potentially preventable (78% in the BedsidePEWS intervention group vs 91%
in the usual care control group). Realizing the potential to prevent these rare serious events and to improve overall patient
outcomes may require other cardiac arrest prevention strategies that operate in other hospital areas,32 and may include increased human health resources, monitoring, and educational interventions.
The strengths of the study include the cluster randomized design, the large size of the trial, the geographic diversity of participating hospitals, complete follow-up of clinically relevant outcome measures, demonstration that the
intervention changed practice, and the use of robust processes to ensure the integrity of the study data, analyses, and
interpretations.

Limitations
This study has several limitations. First, temporal reductions
in mortality provided the rationale for the cluster randomized design3-5; however, the observed mortality was lower than
the conservative estimates used in planning,6,11 and cardiac arrest was infrequent (eTable 4 in Supplement 3). Enrollment of
more hospitals with higher event rates, less diverse characteristics, or from fewer countries may have increased the precision of the results.
Second, descriptions of the 144 539 enrolled patients were
not collected. This may limit the confident generalization of
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Conclusions
Implementation of the Bedside Paediatric Early Warning System compared with usual care did not significantly decrease
all-cause mortality among hospitalized pediatric patients.
These findings do not support the use of this system to reduce mortality.
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the study results to hospitals providing a different range of inpatient services, and to hospitals caring for pediatric patients
of different ages than the regional centers studied.
Third, the study was not blinded. Unmeasured quality initiatives may have narrowed observed differences along with
the BedsidePEWS implementation training of frontline staff
that began during the baseline period.
Fourth, the initial agreement between reviewers was
low for the rating of potentially preventable cardiac arrest.
The assessment method used was based on validated adverse event evaluation methods that were modified to increase reviewer blinding and were supported by reviewer training. Low initial agreement may reflect the subjectivity of
preventability review. In addition, there was a loss of context
associated with presentation of the consistently abstracted
data, which was used to ensure reviewers remained blind to
randomization group.
Fifth, BedsidePEWS is a complex health care intervention that required the actions of multiple persons and teams,
with the intent of becoming embedded in social systems.33 The
evaluation of adherence was mechanistic, focusing on documentation rather than effects on clinical communication and
culture. The 2 sites that withdrew from the study were both
randomized to the BedsidePEWS intervention. The extended
run-in phase lasting 1, 5, and 6 weeks in 3 of the BedsidePEWS
hospitals may have biased the results. However, this also illustrates the practical challenges of conducting clinical trials
that randomize the routine business of hospital inpatient units
to complex health care interventions.
Sixth, the inclusion of mortality with DNR orders was a
pragmatic decision that reflected assumptions that such orders may occur after a preventable clinical deterioration. Uncertainty about the validity of this assumption provided rationale for the conduct of the sensitivity analysis of mortality
after DNR order, and remains a potential limitation of allcause hospital mortality.
Seventh, the generalizability of these results to other less
well-developed or less robustly implemented early warning
scoring systems cannot be assumed. In this trial, implementation was enabled by local teams that were closely overseen
by the Center for Safety Research and a variety of hospitalspecific strategies were used to maintain adherence.
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